Ekso Bionics (EKSO) Set to Announce Earnings on Monday

Ekso Bionics (NASDAQ:EKSO) will be posting its quarterly earnings results after the market closes on Monday, October 28th. Analysts expect Ekso Bionics to post earnings of ($0.08) per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Ekso Bionics (NASDAQ:EKSO) last issued its earnings results on Monday, July 29th. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.02). Ekso Bionics had a negative return on equity of 92.08% and a negative net margin of 68.41%. The company had revenue of $4.95 million during the quarter, compared to analyst estimates of $5.34 million. During the same period in the prior year, the business earned ($0.31) earnings per share. On average, analysts expect Ekso Bionics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Ekso Bionics Price Performance

Shares of NASDAQ EKSO opened at $1.04 on Friday. Ekso Bionics has a 1-year low of $0.75 and a 1-year high of $3.13. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.42 and a quick ratio of 1.77. The business’s fifty day moving average price is $1.10 and its two-hundred day moving average price is $1.15. The firm has a market capitalization of $19.18 million, a PE ratio of -1.32 and a beta of 1.45.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on EKSO shares. StockNews.com started coverage on Ekso Bionics in a research report on Saturday. They issued a “hold” rating on the stock. HC Wainwright reissued a “buy” rating and set a $10.00 price target on shares of Ekso Bionics in a report on Tuesday, July 30th.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.